Literature DB >> 7516595

Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein.

S A Stohlman1, C Bergmann, D Cua, H Wege, R van der Veen.   

Abstract

Thirteen monoclonal antibodies (Mab) specific for the nucleocapsid (N) protein of mouse hepatitis virus were mapped using a panel of carboxy-terminal N protein truncations expressed by recombinant vaccinia viruses. All of the Mab recognized both native protein and full-length N protein expressed in this vector by both Western blot and enzyme-linked immunoabsorbent assays (ELISA), indicating that they recognized linear epitopes. The results obtained by both Western blot and ELISA for binding to the truncated N proteins coincide for seven of the Mab tested. The linear epitopes recognized localize to four domains dispersed between amino acids 171 and 196, 231 and 277, and 374 and 455. The epitopes for six Mab were localized to domains comprising 29 amino acids or less as determined by ELISA. Seven Mab showed different reactivity patterns in Western blot versus ELISA, suggesting binding may be influenced by local conformation. Therefore, the fine specificity of these Mab could not be determined with certainty. These data represent the first determination of antibody binding domains within the mouse hepatitis virus N protein which forms the viral helical nucleocapsids and appears to perform a number of regulatory functions during virus replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516595     DOI: 10.1006/viro.1994.1330

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Control of central nervous system viral persistence by neutralizing antibody.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Roscoe Atkinson; Stephen A Stohlman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.

Authors:  Jiehao Zhou; Stephen A Stohlman; Roscoe Atkinson; David R Hinton; Norman W Marten
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.

Authors:  Stephen A Stohlman; David R Hinton; Beatriz Parra; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis.

Authors:  M T Lin; S A Stohlman; D R Hinton
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA.

Authors:  J M Polo; B Lim; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis.

Authors:  S Kyuwa; M Cohen; G Nelson; S M Tahara; S A Stohlman
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus.

Authors:  Yuxian He; Yusen Zhou; Hao Wu; Zhihua Kou; Shuwen Liu; Shibo Jiang
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

8.  Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis.

Authors:  Carine Savarin; Cornelia C Bergmann; David R Hinton; Richard M Ransohoff; Stephen A Stohlman
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

9.  Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome.

Authors:  Qigai He; Kooi Hoong Chong; Hiok Hee Chng; Bernard Leung; Ai Ee Ling; Ting Wei; Shzu-Wei Chan; Eng Eong Ooi; Jimmy Kwang
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

10.  Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system.

Authors:  S A Stohlman; C C Bergmann; R C van der Veen; D R Hinton
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.